PAINCHEK LTD — AGM Information 2022

Nov 22, 2022

==> picture [462 x 145] intentionally omitted <==

AGM Company Presentation November 2022

Philip Daffas - CEO & Managing Director

PAINCHEK LTD | ASX:PCK

1 |

TH E PR O BLE M

==> picture [237 x 318] intentionally omitted <==

Pain assessment is difficult especially for people living with dementia and preverbal children Pain is often under-detected and under-treated

==> picture [236 x 316] intentionally omitted <==

2

2 |

Our purpose is to give a voice to

==> picture [236 x 316] intentionally omitted <==

==> picture [172 x 299] intentionally omitted <==

==> picture [172 x 299] intentionally omitted <==

==> picture [236 x 316] intentionally omitted <==

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

3 |
----- End of picture text -----

TH E BR E A D T H O F T H E PA IN C H E K GLOB A L MA R KE T OP PORT U N IT Y

400M pre-verbal children

==> picture [318 x 167] intentionally omitted <==

==> picture [313 x 169] intentionally omitted <==

57M people living with dementia >150M expected by 2050

2542% of hospital beds

==> picture [316 x 167] intentionally omitted <==

----- Start of picture text -----

occupied by people with
dementia
----- End of picture text -----

1. Ecology Communications Group. www.ecology.com/birth-death-rates

2. World Alzheimer Report 2016

3. Germossa et al. BMC Nursing (2019) 18:40

4. Tsai, I. P., Jeong, S. Y. S., & Hunter, S. (2018). Pain assessment and management for older patients with dementia in hospitals: an integrative literature review. Pain Management Nursing , 19 (1), 54-71 5. Lancet Public Health – January 2022

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

4 |
----- End of picture text -----

THE PAINCHEK® UNIVERSAL APP: QUICK AND EASY OPERATION

A medical device in your pocket:

Automated facial pain analysis:

• 3 second video of patient face

• recognises 9 micro-facial expressions indicative of pain

Digital questionnaire checklist:

• guides the carer in other pain assessment factors e.g. movement, vocalization etc.

• questions with Yes/No decisions

Automated pain assessment score:

• 42 test points

• generates overall pain score

Documented electronically via cloud backend:

• pain trend line and monitoring of treatment

• capability to integrate into resident medical records

==> picture [212 x 322] intentionally omitted <==

==> picture [197 x 322] intentionally omitted <==

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

5 |
----- End of picture text -----

EXISTING AGED CARE CUSTOMER CONTRACTS

==> picture [403 x 312] intentionally omitted <==

----- Start of picture text -----

CUSTOMER FEE PAYING LICENCES
BEDS / ARR $M
40,000 $1.8
$1.8
$1.6
35,000 $1.6
$1.4
30,000
$1.3
$1.2
25,000
$1.0 $1.0
20,000
$0.8 36,555 $0.8
beds
31,977
15,000
beds
26,501 $0.6
beds
10,000 20,806
17,069 beds $0.4
beds
5,000 $0.2
- $-
SEP-21 DEC-21 MAR-22 JUN-22 SEP-22
Licences paying commercial fees Licences paying commercial fees ($M)
----- End of picture text -----

==> picture [398 x 311] intentionally omitted <==

----- Start of picture text -----

$0.5M $4.2M
$1.5M beds
beds
$0.4M
$1.8M beds
beds
beds
----- End of picture text -----

1.7M+ pain assessments conducted - 10,000+ Carers trained - strong sales pipeline

6

I N T E G R AT I O N PA RT N E R S – Fr o m o n e i n t e g r a t i o n p a r t n e r i n 2 0 1 8 t o 1 6 i n A u s t r a l i a , 7 i n U K / E U , 6 i n N Z a n d 2 i n N o r t h A m e r i c a

PainChek works with aged care management and medication management systems covering more than 180,000 aged care beds in Australia, 25,000 beds in New Zealand, 200,000 beds in the UK and 1,000,000 beds in North America

Beyond aged care, PainChek partners cover a wide variety of industries, including Community/Home Care, Disability Support, Pharmacy, Hospitals, and more.

==> picture [843 x 282] intentionally omitted <==

----- Start of picture text -----

A U S T R A L I A UNITED KINGDOM/EUROPEAN UNION
NEW ZEALAND NORTH
AMERICA
----- End of picture text -----

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

7 |
----- End of picture text -----

PA I N C H E K A D U LT C O R E M A R K E T O P P O RT U N I T Y

AGED CARE DEMENTIA MARKET VALUE Aus UK US ROW est TOTAL No. Aged Care Beds 0.22m 0.54m 1.7m 4.5m 6.96m Annual Market Value @ A$4 per bed per A$11m A$26m A$81m A$216m A$334m month

CONSUMER HOME CARE DEMENTIA MARKET VALUE	CONSUMER HOME CARE DEMENTIA MARKET VALUE	CONSUMER HOME CARE DEMENTIA MARKET VALUE	CONSUMER HOME CARE DEMENTIA MARKET VALUE	CONSUMER HOME CARE DEMENTIA MARKET VALUE	CONSUMER HOME CARE DEMENTIA MARKET VALUE
	Aus	EU	US	ROW est	TOTAL
No. of People living With Dementia at home	0.3m	5.6m	5.1m	32.4m	43.5m
Annual Market Value @ $7 monthly subscription	A$25m	A$475m	A$432m	A$2,720 m	A$3,655 m

• 1 World Alzheimer Report 2016

ratios

• 2 Alzheimer’s Australia key facts & statistics 2017

• 6 Estimated based on Australian population ratios

• 3 ,4 Australian health care statistics

• 7 Management Estimates

==> picture [367 x 501] intentionally omitted <==

----- Start of picture text -----

47 Million living
with dementia
globally –
estimated to
increase to 75
Million by 2025
and 150M by
2050
----- End of picture text -----

• 5 Estimated based on Australian dementia data

8

PA I N C H E K G LO B A L M A R K E T S T R AT E GY

==> picture [493 x 371] intentionally omitted <==

----- Start of picture text -----

Healthcare
PainChek Professionals
Adult
Home
PainChek
Carers
Infant
----- End of picture text -----

==> picture [321 x 74] intentionally omitted <==

BUSINESS MODEL

TARGET MARKETS/USERS

• B2B Enterprise: licence • Hospitals

• Dementia &/geriatric wards

• • ER/Post surgical care

• Residential & home care providers

• Care Homes

• • Home care

• Primary Care

• BUSINESS MODEL TARGET MARKETS/USERS

• B2C Direct to Carer • Mums & Dads Subscription licence • Personal Home Carers • Pharmacy services • Visiting healthcare

• • Retail stores professionals • Direct from supplier • Apple/Google Play Store

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

9 |
----- End of picture text -----

U K – R A PID E N TRY I N T O T H E 44 0, 000 BE D R ESI D E N TI A L A GE D C A R E MA R K E T

==> picture [73 x 73] intentionally omitted <==

UK market traction growing – 8,500 contracted beds with 4,500 live beds and strong pipeline

==> picture [45 x 45] intentionally omitted <==

5 Integrations scheduled with Medication Management (eMAR) partners

==> picture [37 x 38] intentionally omitted <==

Government funded pilots in Scotland & Wales - potential for national roll outs across circa 100,000 beds

==> picture [44 x 44] intentionally omitted <==

7 Care Planning partner integrations covering 285,000 UK beds - 1[st] reseller agreement with Care Vision

==> picture [50 x 50] intentionally omitted <==

New sales with Care UK and Cedar Care in England & Grace Healthcare in Ireland with larger roll out opportunities

==> picture [51 x 45] intentionally omitted <==

Building relations with UK pharmacy providers for Adult app and Infant app distribution

“

The greatest achievement to date s a marked decrease in antipsychotic use in those living with dementia.

Cheryl Baird, Director of Quality and Care at Orchard Care Homes ”

“

We have a resident who struggles to communicate when they are in pain. We undertook a PainChek assessment which confirmed to us the resident was indeed in discomfort.

Using the PainChek assessment data alongside Nourish information, we were able to evidence this to our GP, to support ongoing conversations. We were able to quickly prescribe pain relief and the resident felt much better

”

Louise Rowley – Owner of Heathfield Residential home

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

10 |
----- End of picture text -----

==> picture [160 x 103] intentionally omitted <==

PA I N C H E K H E LPI N G T O IMP R OV E PA IN MA N A GE M EN T OU T C OM E S I N U .K . A G ED C AR E H OM ES

==> picture [264 x 298] intentionally omitted <==

----- Start of picture text -----

Implementation of
PainChek
across 24 homes & 1,365
----- End of picture text -----

Pain management improvements

• 100% increase in frequency of

• pain assessments • 50% increase in number of residents on regular pain relief as a result of newly identified pain • 50% reduction in distressed behaviours thought to be associated with pain

Medication & QoL improvements

• 33% reduction of antipsychotic

• drug use (46% stopped use)

• 29% reduction in use of Benzodiazepines & PRN (46% stopped use)

• 92% reduction in quantity of

• Safeguarding reported incidents

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

* Data collected between March 2020 & September 2021 – 18 month case study 11 |
----- End of picture text -----

MARKET PARTNERSHIP AGREEMENT FOR USA & CANADA AGED CARE

==> picture [279 x 47] intentionally omitted <==

USA – 15,000 nursing homes with 1,700,000 beds Canada – 2,000 care homes with 200,000 beds

==> picture [73 x 73] intentionally omitted <==

==> picture [73 x 73] intentionally omitted <==

PainChek to be integrated into PointClickCare platform providing seamless transition with nursing home’s systems

Pilots in Canada Q4 CY22, USA to commence upon receipt of FDA clearance

PointClickCare is the leading care management software system provider to nursing homes in USA & Canada - 1,000,000+ beds

==> picture [73 x 73] intentionally omitted <==

PointClickCare to market PainChek & its integration capability to its client network

==> picture [73 x 72] intentionally omitted <==

PainChek dedicating resources to taking advantage of this significant North America opportunity

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

12 |
----- End of picture text -----

PA I N C H EK ’ S GLOB A L AG E D C A RE MA R K E T ST R AT E GY

==> picture [896 x 350] intentionally omitted <==

----- Start of picture text -----

Europe (EU)
North America • Targeting RAC beds and
• Marketplace Home care dementia
Partnership finalized patients in EU
with PointClickCare f o r • Exploring International
Japan
North America - UK partnerships with large • Patent secured
providing access to corporates • Initial contacts made
1,000,000+ aged care beds • Direct PainChek UK with pilot sites
presence • Regulatory
• More than 8,500 beds
clearance planned
contracted
• 5+ integration
US / FDA * partners providing
• Adult FDA de Novo in access to ~275,000 ANZ
•
progress targeted Q4 beds Singapore More than 90,000
2023 • Existing RAC RAC beds contracted
• US Patent secured presence • 15+ integration
partners
• Advanced
opportunities in
home care
Countries with regulatory clearance for PainChek covers 10+ countries and 1,000,000 RAC beds and millions of home based clients
----- End of picture text -----

• Regulatory submission & clearance in process

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

13 |
----- End of picture text -----

CONSEQUENCES OF POORLY MANAGED PAIN FOR HOSPITALISED DEMENTIA PATIENTS

==> picture [167 x 18] intentionally omitted <==

----- Start of picture text -----

Longer hospital stay
----- End of picture text -----

Increased delirium risk

High use of Antipsychotics

==> picture [855 x 245] intentionally omitted <==

----- Start of picture text -----

18
3.26
54%
days times
----- End of picture text -----

1. Germossa et al. BMC Nursing (2019) 18:40 https://doi.org/10.1186/s12912-019-0362-y

2. Tsai, I. P., Jeong, S. Y. S., & Hunter, S. (2018). Pain assessment and management for older patients with dementia in hospitals: an integrative literature review. Pain Management Nursing , 19 (1), 54-71. 3. Herr, K. (2011). Pain assessment strategies in older patients. Journal of Pain, 12(3 Suppl 1), S3–s13.

3. Feast AR et al. (2018) Pain and delirium in people with dementia in the acute general hospital setting. Age and Ageing 47, 841–8466-8

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

14 |
----- End of picture text -----

14

PARTNERSHIP WITH INTERSYSTEMS PROVIDES PAINCHEK THE PLATFORM FOR GLOBAL HOSPITAL MARKET ENTRY

• InterSystems – global EMR provider managing more than 1 billion health records

• PainChek mobile App to be integrated with InterSystems IRIS interoperability platform and TrakCare EMR

• Integration addresses hospital workflow and medication management requirements

• Agreement covers PainChek Infants and Adult technologies

• Partnership to can be extended into the home care & other markets

==> picture [497 x 272] intentionally omitted <==

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

15 |
----- End of picture text -----

INTERSYSTEMS TRAKCARE EMR AROUND THE WORLD

==> picture [56 x 56] intentionally omitted <==

500+ TrakCare sites around the globe Deployed in 27 countries Serving a patient population of 100 million+

==> picture [556 x 323] intentionally omitted <==

----- Start of picture text -----

CAMBRIDGE,
USA
World Headquarters
SYDNEY, AU
APAC Regional
Headquarters
----- End of picture text -----

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

16 |
----- End of picture text -----

PA I N C H E K IN H OSP ITAL – D EL IV E R IN G T H E FI F T H V ITA L SIG N

==> picture [420 x 285] intentionally omitted <==

==> picture [189 x 237] intentionally omitted <==

• Germossa et al. BMC Nursing (2019) 18:40

• Tsai, I. P., Jeong, S. Y. S., & Hunter, S. (2018). Pain assessment & management for older patients with dementia in hospitals: an integrative literature review. Pain Management Nursing , 19 (1), 54-71.

• Herr, K. (2011). Pain assessment strategies in older patients. Journal of Pain, 12(3 Suppl 1), S3–s13.

PainChek Integration with Vital Signs monitors and EMR hospital system facilitating Predictive Analytics:

• Early warning alert for nurses

• of a deteriorating patient

• Better post surgical pain management can help reduce the risk of a delirium

• Accurate and rapid pain assessment can reduce the days stay and optimize therapeutic treatments

• Feast AR et al. (2018) Pain & delirium in people with dementia in the acute general hospital setting. Age & Ageing 47, 841–8466-8

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

17 |
----- End of picture text -----

INFANT APP REGULATORY CLEARED FOR SALE IN MULTIPLE MARKETS*

World first facial recognition technology to assess pre-verbal infant post-procedural pain through a 3 second AI based

UK, CE & TGA clearance for Infant version achieved Q2 CY21

US market entry as a Clinical Decision Support tool submitted in Q2 2022

PCK infant clinical study published in Lancet Digital Health November 2021

==> picture [137 x 101] intentionally omitted <==

----- Start of picture text -----

Children’s Hospitals
----- End of picture text -----

1. Post vaccinationPost surgical units

• Health care professionals • Approx. 140 million children born Vaccination centres globally each year with five existing

• General Practitioners immunizations in first year of life.

==> picture [96 x 96] intentionally omitted <==

2. Post operative

• Pain associated with surgical procedures e.g. post tonsillectomy & ENT procedures

==> picture [96 x 96] intentionally omitted <==

3. Partnerships & licensing

• Collaborate with global therapeutic companies providing infant pain medication for health care professionals, families and clinical research*

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

18 |
----- End of picture text -----

1 http://www.ecology.com/birth-death-rates

3 Management Estimates

2 ABS 2016

P R E -V E R B A L C H I L D R E N ’ S PA I N A SS E SS M E N T I S A L A R G E G LO B A L M A R K E T O P P O RT U N I T Y

CONSUMER PRE-VERBAL CHILDREN MARKET VALUE

Indicative App Price A$10/month Net Revenue A$7/month after app store commissions No. 0-3 year olds Worldwide 400m No. Infants 0-1 year worldwide 140m MARKET VALUE EXAMPLES 0.1% Global Market Value 1% Global Market Value

MARKET VALUE EXAMPLES 400k subscribers = A$33.6m Annualised Revenue 4m subscribers = A$336m Annualised Revenue

==> picture [321 x 501] intentionally omitted <==

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

19 |
----- End of picture text -----

CORPORATE SUMMARY

==> picture [321 x 74] intentionally omitted <==

==> picture [960 x 407] intentionally omitted <==

----- Start of picture text -----

Financial information
Share price (22 November 2022) A$0.03
Shares on issue 1,296.4m
A$38.89
Market capitalisation
m
Cash (30 September 2022) A$6.9m
Unlisted options/performance rights 40.6m
Debt Nil
Top shareholders %
Peters Investments Proprietary Ltd 9.14%
Board & key staff 4.2%
----- End of picture text -----

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

20 |
----- End of picture text -----

==> picture [321 x 74] intentionally omitted <==

THE TEAM

==> picture [100 x 100] intentionally omitted <==

==> picture [100 x 100] intentionally omitted <==

==> picture [100 x 100] intentionally omitted <==

==> picture [99 x 102] intentionally omitted <==

Philip Daffas CEO & Managing Director, MBA, BSc

Prof. Jeff Hughes Chief Scientific Officer PhD, MPS

Andrew Hoggan Head of Operations

Iain McAdam CFO

Iain has over 20 years finance & transformational change experience within listed high growth multinational software & services companies, including iSoft & eServGlobal.

Jeff is a professor in the School of Pharmacy, Curtin University in Western Australia. Jeff is one of the team who developed the PainChek® concept.

Philip is a highly accomplished global business leader & people manager. Philip has held senior global leadership positions with Cochlear & Roche in Europe, US & Australia.

Andy is a Psychologist, management consultant, business leader & executive coach. Andrew has worked in both Australia & the UK across aged care & home care services.

==> picture [100 x 103] intentionally omitted <==

==> picture [95 x 103] intentionally omitted <==

==> picture [98 x 103] intentionally omitted <==

Scott Robertson Chief Technology Officer, MBA, B.Eng.(Comp. Systems)

Tandeep Gill Senior Business Development Manager, UK

David Allsopp Head of Business Development ANZ

David has extensive account management, relationship management. He is renowned for establishing trusting, transparent & long-standing relationships in the healthcare space.

Tandeep is a registered pharmacist in both the hospital & community setting, with ten years experience in senior health & social care positions. He has spent three years leading the advancement of technology solutions in the UK.

Scott has over 25 years’ experience designing, deploying & managing enterprise software systems, adapting to changing client needs.

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

21 |
----- End of picture text -----

THE BOARD

==> picture [165 x 166] intentionally omitted <==

John Murray Chairman

John Murray Non-Exec Chair

Philip Daffas CEO & Managing Director

25 years in tech & Venture Capital. Founder of Technology Venture Partners, ex Chair of Residential Aged Care provider. Multiple nonexec board roles.

Philip is a highly accomplished global business leader & people manager. Philip has held senior global leadership positions with Cochlear & Roche in Europe, US & Australia.

==> picture [166 x 169] intentionally omitted <==

Ross Harricks Non-Exec Director

Senior global medical device executive with Nucleus & experienced healthcare NED.

==> picture [321 x 74] intentionally omitted <==

==> picture [166 x 168] intentionally omitted <==

==> picture [161 x 168] intentionally omitted <==

Adam Davey Non-Exec Director

Cynthia Payne Non-Exec Director

Corporate finance

30 years executive

executive with extensive capital markets experience.

leadership experience as well as significant board and operational experience in residential and home aged care services in Australia.

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

22 |
----- End of picture text -----

PA I NC H E K C O MPA N Y H I GH LI GH T S

==> picture [64 x 142] intentionally omitted <==

==> picture [63 x 220] intentionally omitted <==

PROVEN & DOMINANT MARKET POSITION IN AU

RAPIDLY GROWING ARR WITH STRONG RETENTION RATE

==> picture [63 x 63] intentionally omitted <==

INTERNATIONAL EXPANSION UNDERWAY VIA ESTABLISHED INTEGRATION PARTNERS

==> picture [321 x 74] intentionally omitted <==

PATENT PROTECTED OFFERING IMPROVING OUTCOMES FOR PATIENTS

UNTAPPED POTENTIAL IN INFANTS/CHILDREN’S MARKET

MULTIPLE LARGE GLOBAL MARKET OPPORTUNITIES

==> picture [961 x 37] intentionally omitted <==

----- Start of picture text -----

23 |
----- End of picture text -----

==> picture [321 x 74] intentionally omitted <==

==> picture [414 x 129] intentionally omitted <==

CONTACT

Philip Daffas, CEO & MD philip.daffas@painchek.com

24 |